Farms.com Home   News

Ultrafiltered Milk Sparks a U.S.-Canada Trade Battle

A fight over a little-known dairy product sits at the center of increasing tensions between the U.S. and Canada over broader trade issues.
 
If the dispute goes unresolved, some observers say, it could have ripple effects in global dairy markets. It also could contribute to efforts by some, including advisers within the Trump administration, to dramatically reshape the North American Free Trade Agreement, which some experts warn could be a disaster for U.S. farmers.
 
Here’s what is happening. U.S. dairy farmers and processors in Wisconsin, New York and Minnesota have been hurt by a newly adopted Canadian pricing policy that encourages Canadian dairies to buy certain types of milk products domestically. The specific product in the trade dispute is a milk-protein concentrate called ultrafiltered milk that is used primarily in cheese-making to increase yields.
 
In 2016, the U.S. exported $102 million in ultrafiltered milk to Canada, according to the U.S. Agriculture Department. But industry observers estimate that exports have dropped to near zero since February, when Canada created a nationwide dairy classification that lowered the price of Canadian milk used to make ultrafiltered milk.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.